SCHEMBL8097749

SCHEMBL8097749

CC(C)S(=O)(=O)NC(=O)Nc1ccc(F)c(Cl)c1.[NaH]

nearest known ligand 0.60

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.60
SLC2A1 P11166 1/20 0.58
MEN1 O00255 6/20 0.58
KMT2A Q03164 6/20 0.58
HTT P42858 3/20 0.58
SMN1; SMN2 Q16637 3/20 0.58
NPC1 O15118 2/20 0.58
RAB9A P51151 2/20 0.58
CA2 P00918 1/20 0.56
TSHR P16473 2/20 0.56
KDM4E B2RXH2 1/20 0.56
MAPT P10636 4/20 0.54
CASP3 P42574 1/20 0.53
SENP7 Q9BQF6 1/20 0.53
ALDH1A1 P00352 1/20 0.52
IDH1 O75874 2/20 0.52
L3MBTL1 Q9Y468 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8094995 0.99 LMNA (0.61) LMNASLC2A1MEN1KMT2AHTT
SCHEMBL8083369 0.87 MEN1 (0.59) LMNASLC2A1MEN1KMT2AHTT
SCHEMBL8083234 0.86 EPHX1 (0.62) LMNASLC2A1MEN1KMT2AHTT
SCHEMBL8083304 0.83 ALDH1A1 (0.54) LMNAMEN1KMT2AHTTSMN1; SMN2
SCHEMBL8091346 0.81 ALDH1A1 (0.56) LMNAMEN1KMT2AHTTSMN1; SMN2
SCHEMBL8091318 0.80 TP53 (0.56) MEN1KMT2AHTTSMN1; SMN2NPC1
SCHEMBL8091387 0.79 KDR (0.68) CA2
SCHEMBL20290535 0.78 TSHR (0.51) LMNASLC2A1MEN1KMT2AHTT
SCHEMBL9341223 0.78 NPC1 (0.48) LMNASLC2A1MEN1KMT2AHTT
SCHEMBL12530409 0.76 MEN1 (0.79) LMNASLC2A1MEN1KMT2AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6147115-A SULFONYLUREIDO-4-HALOBENZENE DERIVATIVES; ANTICARCINOGENIC AGENTS ELI LILLY AND COMPANY (US) 2000-11-14 US disclosed
EP-0467621-B1 N-phenyl-N'-alkylsulfonylureas, process for their preparation and antitumor compositions containing them LILLY CO ELI (US) 1994-06-15 EP disclosed
US-5216026-A Administering to the mammal N-1-butanesulfonamide derivatives and salts ELI LILLY AND COMPANY (US) 1993-06-01 US disclosed
EP-0467621-A1 N-phenyl-N'-alkylsulfonylureas, process for their preparation and antitumor compositions containing them ELI LILLY AND COMPANY (US) 1992-01-22 EP disclosed